Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan

Stefano Omboni, Massimo Volpe
  • Advances in Therapy, December 2018, Springer Science + Business Media
  • DOI: 10.1007/s12325-018-0859-x

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Prof. Stefano Omboni